z.yildiz

TL2 · Angers

Contributes reviews on supplier material. Based in Angers.

Joined 1 September 2025 · last posted 8h

74 posts, newest first. Showing up to 150.

Revisiting: Body image changing more slowly than the body Replied, post #10 · Wellbeing › Mental health · 28 Jul 2026 · 11 likes Post #6 describes the usual case. This is about the unusual one. Motivation and expectation: starting with clear motivation and realistic expectations about what will…
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #26 · Compounds › Secretagogues & GH axis · 20 Jul 2026 · 16 likes Post #23 answers the question as asked. The question underneath it is different. Storage: these are lyophilised short peptides and are generally reasonably stable dry…
Revisiting: The best-written scientific paper you have read Replied, post #102 · Lounge › Off topic · 19 Jul 2026 · 0 likes Analytics first, in my case, and I still find the practice category the harder read. Chromatography has one right answer more often than logistics does.
Revisiting: The best-written scientific paper you have read Replied, post #89 · Lounge › Off topic · 13 Jul 2026 · 16 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
Reading a home test result without over-claiming Replied, post #114 · Analytics › Home & field testing · 11 Jul 2026 · 5 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
Asking a follow-up: new topic or new reply? Replied, post #44 · Start Here › How to Ask · 9 Jul 2026 · 7 likes Post #42 and I disagree about the size of the effect, not about the direction. Where I would push back on the asking a follow-up consensus is the confidence, not the…
What I would want from a home test that does not exist yet Replied, post #29 · Analytics › Home & field testing · 6 Jul 2026 · 10 likes Answering the question post #27 raises rather than the one it answers. The honest cost comparison is a home kit against a single independent submission. For most people…
What to bring: records that a clinician can actually use — a second dataset Replied, post #4 · Clinical › Prescriber conversations · 3 Jul 2026 · 0 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. Bringing a record of symptoms with dates and severities makes an assessment…
Follow-up: UK access routes, dated and sourced Replied, post #8 · Regional › UK & Ireland · 30 Jun 2026 · 13 likes Correcting an out-of-date claim in this subcategory with a source and a date is more valuable than a new topic on the same question. A weak preference rather than a…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #41 · Access › International · 27 Jun 2026 · 1 like Worth separating two things that post #39 runs together. Temperature-controlled material and long-haul travel is a practical problem with practical solutions, none of…
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #58 · Analytics › Home & field testing · 26 Jun 2026 · 0 likes The honest cost comparison is a home kit against a single independent submission. For most people the second answers the question and the first answers a different,…
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #12 · Compounds › Semaglutide · 19 Jun 2026 · 0 likes I read post #10 twice before replying, because I had assumed the opposite. Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects.…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #26 · Access › Insurance & coverage · 18 Jun 2026 · 0 likes Adding a small correction to the Prior authorisation summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that…
Reading a home test result without over-claiming Replied, post #81 · Analytics › Home & field testing · 16 Jun 2026 · 0 likes Everything in post #77 holds. The case it does not cover is the one I have. Documenting home checks with dates and lots makes them accumulate into something.…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #89 · Practice › Side effects · 4 Jun 2026 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
Carryover and the ghost peak from last week's standard — what changed since Replied, post #3 · marked as the solution · Analytics › HPLC & UHPLC · 3 Jun 2026 · 7 likes My experience of Carryover contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #102 · Devices › Syringes & needles · 9 May 2026 · 2 likes Graduation spacing is worth checking before you buy rather than after. Some 1 mL barrels are marked every two units and some every one, and that changes what doses you…
Second pass at: When your prescriber and the evidence disagree Replied, post #14 · Clinical › Prescriber conversations · 25 Apr 2026 · 4 likes Before the thread moves on from prescriber — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #106 · Pharmacology › Pharmacokinetics · 15 Apr 2026 · 15 likes A note on how Washout gets discussed rather than on Washout itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been…
List price versus negotiated price versus what you pay Replied, post #6 · Access › Pricing · 7 Apr 2026 · 2 likes Post #4 describes the usual case. This is about the unusual one. List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an…
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #8 · Compounds › Retatrutide · 2 Apr 2026 · 2 likes Narrowing post #7, because the general version has more than one answer. The evidence status here should be stated in the first line of any post about it rather than…
Follow-up: Search filters: what is missing Replied, post #65 · Meta › Site feedback · 30 Mar 2026 · 16 likes Post #64 answers the question as asked. The question underneath it is different. Feature requests: if the site would work better with a feature it does not have (better…
Reconstitution volumes that produce round numbers, tabulated Replied, post #77 · Practice › Reconstitution · 28 Mar 2026 · 0 likes Adding the measurement that post #75 says would settle it. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go…
How to ask about something you suspect is a bad idea Replied, post #66 · Start Here › How to Ask · 17 Mar 2026 · 25 likes This follows post #63 rather than contradicting it. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you…
Forced degradation studies: designing one that is informative Replied, post #19 · Analytics › Method validation · 13 Mar 2026 · 1 like Post #17 describes the usual case. This is about the unusual one. System suitability is the ongoing evidence that a validated method is still performing. Validation is…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #14 · Compounds › Oral incretins · 2 Mar 2026 · 0 likes The arithmetic in post #11 is right; the assumption feeding it is the part to check. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy…
Managing an unplanned gap in supply Replied, post #43 · Access › Shortages · 26 Feb 2026 · 0 likes Nothing here is medical advice, and decisions about what to do during a supply interruption belong with a prescriber.
Moderation log format change Replied, post #28 · Meta › Announcements · 11 Feb 2026 · 0 likes Moderation log format change was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Trifluoroacetate content and its consequences Replied, post #36 · Analytics › Impurities & related substances · 28 Jan 2026 · 32 likes On post #32 — agreed on the reasoning, with one qualification. Summarising the trifluoroacetate content thread so far, since it is long and the answer is buried: the…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #2 · Analytics › Mass spectrometry · 4 Jan 2026 · 5 likes Practical note on Adducts: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #75 · Compounds › Oral incretins · 4 Dec 2025 · 6 likes Adding the measurement that post #72 says would settle it. Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #69 · Compounds › Oral incretins · 4 Dec 2025 · 6 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
The headache that turns out to be dehydration Replied, post #68 · Nutrition & Training › Hydration & electrolytes · 24 Nov 2025 · 29 likes Post #65 answers the question as asked. The question underneath it is different. The practical version of headache is three sentences long. The rigorous version is…
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #15 · Practice › Side effects · 23 Nov 2025 · 0 likes I read post #11 twice before replying, because I had assumed the opposite. Small correction to my own earlier position on Injection-site reactions. I had the units the…
Substitution between formats during a shortage Replied, post #84 · Access › Shortages · 28 Oct 2025 · 1 like Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
Managing an unplanned gap in supply — what changed since Replied, post #98 · Access › Shortages · 26 Oct 2025 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
Follow-up: What a seizure notice actually says Replied, post #20 · Sourcing › Logistics · 25 Oct 2025 · 5 likes Two questions I would want answered before drawing anything from the seizure notice data above: how were the cases selected, and what happened to the ones that dropped…
Washout: how long is long enough, and for what purpose Replied, post #71 · Pharmacology › Pharmacokinetics · 27 Sep 2025 · 1 like Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #24 · Compounds › Tirzepatide · 20 Sep 2025 · 8 likes Worth separating two things that post #22 runs together. On the mechanism question specifically: the honest position is that GIP agonism plausibly contributes and that…
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #56 · Practice › Storage & stability · 19 Sep 2025 · 11 likes Small methodological point on Freeze-thaw: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Power cut for eleven hours: how I assessed it afterwards Replied, post #62 · Practice › Storage & stability · 18 Sep 2025 · 21 likes Temperature excursions in transit are common and are not all equal. A few hours warm is a different event from three days warm, and neither is visible in the vial on…
Are there stupid questions here? A staff answer, at length Replied, post #10 · Start Here › Welcome · 24 Jul 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Asking about a compound your prescriber has not heard of Replied, post #91 · Clinical › Prescriber conversations · 11 Jul 2025 · 0 likes Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
Why plausible mechanism is not evidence of effect Replied, post #19 · Compounds › Repair & healing peptides · 3 Jul 2025 · 2 likes Where I part company with post #15, and it is a narrow parting. I have three months of notes on plausible mechanism and the honest summary is that the trend is real and…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #77 · Nutrition & Training › Protein & intake · 13 Jun 2025 · 0 likes Narrowing post #76, because the general version has more than one answer. I have no financial interest in anything named in this thread and I want to say so before I…
Reading a trial's population section before its results — does this still hold? Replied, post #148 · Evidence › Trials · 26 May 2025 · 19 likes I read post #147 twice before replying, because I had assumed the opposite. A treatment-policy estimand asks what happens to people assigned to a strategy, including…
When to stop reading forums, including this one — the long version Replied, post #18 · Wellbeing › Mental health · 14 May 2025 · 9 likes Picking up post #15: that is the part I would want checked first. Maintenance brings a different set of psychological questions from loss, and the discussion here is…
Reading a trial's population section before its results — does this still hold? Replied, post #96 · Evidence › Trials · 12 May 2025 · 26 likes Entry criteria, run-in periods and the self-selection of people willing to enter a multi-year trial all narrow the population. That is how internal validity is bought…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #70 · Compounds › Tirzepatide · 26 Apr 2025 · 3 likes That is a fair summary of where the discussion has got to.
Sequence verification for an obscure compound: how it is done Replied, post #18 · Compounds › Other compounds · 23 Apr 2025 · 4 likes Fragment compounds — where the material is part of a larger natural protein — should be identified by sequence rather than by name, because the naming in this space is…
Retatrutide dose escalation in the published trials Replied, post #149 · Compounds › Retatrutide · 18 Apr 2025 · 0 likes Everything in post #145 holds. The case it does not cover is the one I have. A theoretical mass for retatrutide is not published in the peer-reviewed literature in a…
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #57 · Evidence › Journal club · 14 Apr 2025 · 0 likes Post #54 is the version of this I will quote in future. One addition. Small methodological point on STEP 4: repeating a measurement is cheap and resolves most of what…
Second pass at: A single out-of-range value on an otherwise normal panel Replied, post #14 · Clinical › Bloodwork · 2 Apr 2025 · 13 likes I had written a reply contradicting post #11 and deleted it. Here is what survived. Agreed on single out-of-range value, with one qualification that I think matters.…
Coverage for the indication versus for the drug — a second dataset Replied, post #41 · Access › Insurance & coverage · 25 Mar 2025 · 11 likes Picking up post #38: that is the part I would want checked first. Coverage for weight management versus diabetes: many formularies cover these compounds for type 2…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #80 · Compounds › Semaglutide · 27 Feb 2025 · 0 likes Building on post #77 rather than restating it. Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #16 · Pharmacology › Receptor biology · 27 Feb 2025 · 22 likes Post #13 is right about the mechanism and I think understates the practical bit. Species differences in receptor pharmacology are substantial in this family, which is…
Coming back to: Official shortage notices and what they authorise Replied, post #41 · Access › Shortages · 25 Feb 2025 · 30 likes Post #37 describes the usual case. This is about the unusual one. Shortage predictions: regulators and suppliers issue shortage alerts before they become acute.…
Review: a draft on reconstitution arithmetic, with objections Replied, post #27 · Documentation › Doc review · 19 Feb 2025 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
Protein density versus volume when you cannot eat much Replied, post #9 · Nutrition & Training › Protein & intake · 23 Jan 2025 · 2 likes Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body weight. Individual requirements vary but that range is a…
What changed in 2026, by region Replied, post #93 · Access › International · 22 Jan 2025 · 7 likes Where I part company with post #89, and it is a narrow parting. Date your answer and name your region. A position that is true in one jurisdiction and stated without…
Telehealth prescribing models in the US Replied, post #38 · Regional › North America · 27 Dec 2024 · 9 likes Where a manufacturer runs a direct supply route, that is a commercial arrangement rather than a regulatory change, and it can end. Written quickly, so the reasoning may…
SURPASS-2 and the comparator dose question that will not go away Replied, post #86 · Compounds › Tirzepatide · 23 Dec 2024 · 28 likes On the mechanism question specifically: the honest position is that GIP agonism plausibly contributes and that the trial design cannot separate its contribution from…
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #2 · Practice › Administration · 17 Dec 2024 · 16 likes Air in the syringe is a much smaller problem subcutaneously than the anxiety about it suggests, and it is still worth expelling because the bubble occupies volume you…
Converting between mg/mL and units per dose, both directions Replied, post #125 · Practice › Reconstitution · 11 Dec 2024 · 5 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. I would…
Two sessions a week versus four: what the evidence supports Replied, post #18 · Nutrition & Training › Resistance training · 29 Nov 2024 · 0 likes This follows post #15 rather than contradicting it. Nothing here is medical advice and anybody with a relevant condition should have a programme reviewed by somebody…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #32 · Compounds › Semaglutide · 26 Oct 2024 · 4 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
Converting between mg/mL and units per dose, both directions Replied, post #47 · Practice › Reconstitution · 11 Oct 2024 · 4 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Progressive overload when the scale is falling — one year on Replied, post #141 · Nutrition & Training › Resistance training · 9 Oct 2024 · 16 likes What I want from this Progressive overload thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #69 · Clinical › Bloodwork · 30 Sep 2024 · 0 likes Worth separating two things that post #67 runs together. A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a…
A rising related-substance total over six months: degradation or method drift? Replied, post #23 · Analytics › Impurities & related substances · 31 Aug 2024 · 17 likes Storage-related degradation and synthesis-related impurity look different on a chromatogram. A growing oxidation peak over time is not a manufacturing finding. Worth…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #20 · Evidence › Journal club · 18 Aug 2024 · 5 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
Second pass at: Journal club: LEADER as the historical anchor Replied, post #35 · Evidence › Journal club · 17 Jul 2024 · 0 likes I read post #31 twice before replying, because I had assumed the opposite. What would change my mind on LEADER is a second dataset collected by someone with no stake in…
How this community labels and discusses unrefereed work Replied, post #74 · Evidence › Preprints · 10 Jul 2024 · 0 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion.
Spreadsheets: an appreciation Replied, post #6 · Lounge › Off topic · 5 Jun 2024 · 15 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.